000			01641 a2200445 4500
005			20250516011424.0
264		0	_c20101110
008			201011s 0 0 eng d
022			_a1879-1891
024	7		_a10.1016/j.ajo.2010.07.021 _2doi
040			_aNLM _beng _cNLM
100	1		_aChhablani, Jay Kumar
245	0	0	_aPhotodynamic therapy for polypoidal choroidal vasculopathy. _h[electronic resource]
260			_bAmerican journal of ophthalmology _cNov 2010
300			_a754-5; author reply 755 p. _bdigital
500			_aPublication Type: Letter; Comment
650	0	4	_aAngiogenesis Inhibitors _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aBevacizumab
650	0	4	_aChoroid _xblood supply
650	0	4	_aChoroid Diseases _xdiagnosis
650	0	4	_aCombined Modality Therapy
650	0	4	_aFluorescein Angiography
650	0	4	_aHumans
650	0	4	_aInjections
650	0	4	_aPeripheral Vascular Diseases _xdiagnosis
650	0	4	_aPhotochemotherapy
650	0	4	_aPhotosensitizing Agents _xtherapeutic use
650	0	4	_aPorphyrins _xtherapeutic use
650	0	4	_aRetreatment
650	0	4	_aTomography, Optical Coherence
650	0	4	_aTreatment Outcome
650	0	4	_aVascular Endothelial Growth Factor A _xantagonists & inhibitors
650	0	4	_aVerteporfin
650	0	4	_aVisual Acuity _xphysiology
650	0	4	_aVitreous Body
773	0		_tAmerican journal of ophthalmology _gvol. 150 _gno. 5 _gp. 754-5; author reply 755
856	4	0	_uhttps://doi.org/10.1016/j.ajo.2010.07.021 _zAvailable from publisher's website
999			_c20336051 _d20336051